<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>isageo &#187; human papillomavirus</title>
	<atom:link href="http://www.isageo.com/tag/human-papillomavirus/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.isageo.com</link>
	<description>about all aspects of life</description>
	<lastBuildDate>Thu, 19 Jan 2012 12:14:36 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>New HPV vaccine under study in Vienna</title>
		<link>http://www.isageo.com/2009/12/new-hpv-vaccine-under-study-in-vienna/</link>
		<comments>http://www.isageo.com/2009/12/new-hpv-vaccine-under-study-in-vienna/#comments</comments>
		<pubDate>Mon, 14 Dec 2009 19:45:12 +0000</pubDate>
		<dc:creator>isa</dc:creator>
				<category><![CDATA[Science]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://www.isageo.com/?p=152</guid>
		<description><![CDATA[Last summer, a certain flyer on the pin board got my attention: A new HPV vaccine is currently under study at the AKH Vienna. Well, what is the difference between this new vaccine and the “old” one? The human papillomavirus vaccine GARDASIL® which is currently on the market is quadrivalent. This means that it prevents [...]]]></description>
			<content:encoded><![CDATA[<p>Last summer, a certain flyer on the pin board got my attention:</p>
<p>A new HPV vaccine is currently under study at the AKH Vienna.</p>
<p>Well, what is the difference between this new vaccine and the “old” one?</p>
<p>The human papillomavirus vaccine GARDASIL® which is currently on the market is quadrivalent. This means that it prevents the infection of 4 different types of human papillomaviruses. The protection is directed against two types (HPV-16 and HPV-18) which can cause cervical cancer, and two other types (HPV-6 and HPV-11) which are responsible for the formation of genital warts.</p>
<p>The new HPV vaccine under study is a nine-valent vaccine. It consists, as the previous one, of hollow virus-like particles assembled from recombinant HPV coat proteins. The nine-valent vaccine is meant to protect against 5 additional HPV types. In this study, the new vaccine is compared to the quadrivalent one.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.isageo.com/2009/12/new-hpv-vaccine-under-study-in-vienna/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

